nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—HBA2—Scavenging of heme from plasma—AMBP—nephrolithiasis	0.158	0.277	CbGpPWpGaD
Mefloquine—HBA1—Scavenging of heme from plasma—AMBP—nephrolithiasis	0.12	0.21	CbGpPWpGaD
Mefloquine—HBA2—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.074	0.129	CbGpPWpGaD
Mefloquine—HBA2—Binding and Uptake of Ligands by Scavenger Receptors—AMBP—nephrolithiasis	0.0632	0.11	CbGpPWpGaD
Mefloquine—HBA1—urine—nephrolithiasis	0.06	0.362	CbGeAlD
Mefloquine—HBA1—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.0561	0.098	CbGpPWpGaD
Mefloquine—HBA1—Binding and Uptake of Ligands by Scavenger Receptors—AMBP—nephrolithiasis	0.0479	0.0837	CbGpPWpGaD
Mefloquine—Anxiety disorder—Hydrochlorothiazide—nephrolithiasis	0.0395	0.151	CcSEcCtD
Mefloquine—Conduction disorder—Hydrochlorothiazide—nephrolithiasis	0.0291	0.111	CcSEcCtD
Mefloquine—HBA1—renal system—nephrolithiasis	0.0147	0.0885	CbGeAlD
Mefloquine—HBA1—kidney—nephrolithiasis	0.0142	0.0856	CbGeAlD
Mefloquine—HBA2—renal system—nephrolithiasis	0.0135	0.0813	CbGeAlD
Mefloquine—HBA2—kidney—nephrolithiasis	0.013	0.0786	CbGeAlD
Mefloquine—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.00951	0.0363	CcSEcCtD
Mefloquine—CYP3A4—urine—nephrolithiasis	0.00814	0.0491	CbGeAlD
Mefloquine—CYP2D6—urine—nephrolithiasis	0.00801	0.0483	CbGeAlD
Mefloquine—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.00778	0.0297	CcSEcCtD
Mefloquine—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00622	0.0237	CcSEcCtD
Mefloquine—ADORA1—renal system—nephrolithiasis	0.00605	0.0365	CbGeAlD
Mefloquine—ADORA1—kidney—nephrolithiasis	0.00585	0.0353	CbGeAlD
Mefloquine—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00573	0.0219	CcSEcCtD
Mefloquine—ADORA1—cortex of kidney—nephrolithiasis	0.0057	0.0344	CbGeAlD
Mefloquine—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00512	0.0195	CcSEcCtD
Mefloquine—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00468	0.0178	CcSEcCtD
Mefloquine—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00436	0.0166	CcSEcCtD
Mefloquine—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.0042	0.016	CcSEcCtD
Mefloquine—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00417	0.0159	CcSEcCtD
Mefloquine—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00399	0.0152	CcSEcCtD
Mefloquine—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00391	0.0149	CcSEcCtD
Mefloquine—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00344	0.0131	CcSEcCtD
Mefloquine—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00339	0.0129	CcSEcCtD
Mefloquine—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00336	0.0128	CcSEcCtD
Mefloquine—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00335	0.0128	CcSEcCtD
Mefloquine—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00328	0.0125	CcSEcCtD
Mefloquine—BCHE—nephron tubule—nephrolithiasis	0.00325	0.0196	CbGeAlD
Mefloquine—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00319	0.0122	CcSEcCtD
Mefloquine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00312	0.0119	CcSEcCtD
Mefloquine—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00296	0.0113	CcSEcCtD
Mefloquine—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.0029	0.0111	CcSEcCtD
Mefloquine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00286	0.0109	CcSEcCtD
Mefloquine—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00285	0.0109	CcSEcCtD
Mefloquine—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00271	0.0103	CcSEcCtD
Mefloquine—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00267	0.0102	CcSEcCtD
Mefloquine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00257	0.00979	CcSEcCtD
Mefloquine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00252	0.00959	CcSEcCtD
Mefloquine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0025	0.00954	CcSEcCtD
Mefloquine—ADORA1—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00249	0.00435	CbGpPWpGaD
Mefloquine—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00248	0.00944	CcSEcCtD
Mefloquine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00245	0.00935	CcSEcCtD
Mefloquine—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00241	0.00918	CcSEcCtD
Mefloquine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.0024	0.00915	CcSEcCtD
Mefloquine—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00239	0.00913	CcSEcCtD
Mefloquine—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00239	0.00911	CcSEcCtD
Mefloquine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00236	0.009	CcSEcCtD
Mefloquine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00235	0.00895	CcSEcCtD
Mefloquine—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00227	0.00867	CcSEcCtD
Mefloquine—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00227	0.00867	CcSEcCtD
Mefloquine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00227	0.00867	CcSEcCtD
Mefloquine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00227	0.00864	CcSEcCtD
Mefloquine—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00225	0.00856	CcSEcCtD
Mefloquine—HBA2—Metabolism—GRHPR—nephrolithiasis	0.00221	0.00387	CbGpPWpGaD
Mefloquine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.0022	0.00838	CcSEcCtD
Mefloquine—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00218	0.00831	CcSEcCtD
Mefloquine—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00218	0.00831	CcSEcCtD
Mefloquine—Shock—Hydrochlorothiazide—nephrolithiasis	0.00214	0.00817	CcSEcCtD
Mefloquine—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00213	0.00813	CcSEcCtD
Mefloquine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00213	0.00811	CcSEcCtD
Mefloquine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00211	0.00803	CcSEcCtD
Mefloquine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00204	0.00776	CcSEcCtD
Mefloquine—ADORA2A—GPCRs, Other—CHRM3—nephrolithiasis	0.002	0.0035	CbGpPWpGaD
Mefloquine—CYP3A4—renal system—nephrolithiasis	0.00199	0.012	CbGeAlD
Mefloquine—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00199	0.00757	CcSEcCtD
Mefloquine—HBA2—Metabolism—AGXT—nephrolithiasis	0.00197	0.00345	CbGpPWpGaD
Mefloquine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00197	0.00751	CcSEcCtD
Mefloquine—CYP2D6—renal system—nephrolithiasis	0.00196	0.0118	CbGeAlD
Mefloquine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00196	0.00746	CcSEcCtD
Mefloquine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00194	0.00741	CcSEcCtD
Mefloquine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00194	0.00739	CcSEcCtD
Mefloquine—CYP3A4—kidney—nephrolithiasis	0.00192	0.0116	CbGeAlD
Mefloquine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00192	0.00731	CcSEcCtD
Mefloquine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00189	0.00722	CcSEcCtD
Mefloquine—CYP2D6—kidney—nephrolithiasis	0.00189	0.0114	CbGeAlD
Mefloquine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00188	0.00716	CcSEcCtD
Mefloquine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.0018	0.00685	CcSEcCtD
Mefloquine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00178	0.00679	CcSEcCtD
Mefloquine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00173	0.0066	CcSEcCtD
Mefloquine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00172	0.00657	CcSEcCtD
Mefloquine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00172	0.00657	CcSEcCtD
Mefloquine—HBA1—Metabolism—GRHPR—nephrolithiasis	0.00168	0.00293	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—APRT—nephrolithiasis	0.00168	0.00293	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—SLC26A1—nephrolithiasis	0.00168	0.00293	CbGpPWpGaD
Mefloquine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00161	0.00612	CcSEcCtD
Mefloquine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00156	0.00596	CcSEcCtD
Mefloquine—ABCB1—nephron tubule—nephrolithiasis	0.00155	0.00935	CbGeAlD
Mefloquine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00154	0.00588	CcSEcCtD
Mefloquine—HBA1—Metabolism—AGXT—nephrolithiasis	0.00149	0.00261	CbGpPWpGaD
Mefloquine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00149	0.00568	CcSEcCtD
Mefloquine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00144	0.00549	CcSEcCtD
Mefloquine—ADORA2A—G alpha (s) signalling events—PTH—nephrolithiasis	0.00143	0.0025	CbGpPWpGaD
Mefloquine—ABCB1—renal system—nephrolithiasis	0.00141	0.0085	CbGeAlD
Mefloquine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00139	0.00528	CcSEcCtD
Mefloquine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00137	0.00524	CcSEcCtD
Mefloquine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00137	0.00523	CcSEcCtD
Mefloquine—CYP19A1—Biological oxidations—SLC26A1—nephrolithiasis	0.00137	0.0024	CbGpPWpGaD
Mefloquine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00137	0.0052	CcSEcCtD
Mefloquine—ABCB1—kidney—nephrolithiasis	0.00136	0.00822	CbGeAlD
Mefloquine—ABCB1—cortex of kidney—nephrolithiasis	0.00133	0.00801	CbGeAlD
Mefloquine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00129	0.00493	CcSEcCtD
Mefloquine—HBA1—Metabolism—SLC26A1—nephrolithiasis	0.00127	0.00222	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—APRT—nephrolithiasis	0.00127	0.00222	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—AQP1—nephrolithiasis	0.00119	0.00209	CbGpPWpGaD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00113	0.00197	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—CHRM3—nephrolithiasis	0.00108	0.00189	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000966	0.00169	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—AQP1—nephrolithiasis	0.000905	0.00158	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00087	0.00152	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000851	0.00149	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—CHRM3—nephrolithiasis	0.000818	0.00143	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—RGS14—nephrolithiasis	0.000773	0.00135	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000746	0.0013	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000736	0.00129	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—PTH—nephrolithiasis	0.000673	0.00118	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000657	0.00115	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.000612	0.00107	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—RGS14—nephrolithiasis	0.000597	0.00104	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000575	0.00101	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000568	0.000993	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—ADCY10—nephrolithiasis	0.000537	0.000939	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—DGKH—nephrolithiasis	0.000522	0.000913	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—PTH—nephrolithiasis	0.000519	0.000908	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—RGS14—nephrolithiasis	0.000457	0.000798	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000444	0.000776	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000416	0.000727	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—ADCY10—nephrolithiasis	0.000415	0.000725	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000413	0.000722	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000413	0.000722	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—DGKH—nephrolithiasis	0.000403	0.000705	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.0004	0.0007	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—PTH—nephrolithiasis	0.00038	0.000665	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000377	0.00066	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000368	0.000644	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—RGS14—nephrolithiasis	0.000353	0.000616	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—PTH—nephrolithiasis	0.000345	0.000604	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GRHPR—nephrolithiasis	0.000337	0.000589	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000337	0.000589	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000337	0.000589	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000321	0.000561	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GRHPR—nephrolithiasis	0.000309	0.000541	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—DGKH—nephrolithiasis	0.000308	0.000539	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000308	0.000539	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GRHPR—nephrolithiasis	0.0003	0.000525	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—AGXT—nephrolithiasis	0.0003	0.000525	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—PTH—nephrolithiasis	0.000294	0.000513	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000291	0.00051	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—AGXT—nephrolithiasis	0.000276	0.000482	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—AGXT—nephrolithiasis	0.000268	0.000468	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—PTH—nephrolithiasis	0.000267	0.000466	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—SLC26A1—nephrolithiasis	0.000255	0.000446	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—APRT—nephrolithiasis	0.000255	0.000446	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000255	0.000446	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000255	0.000446	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—DGKH—nephrolithiasis	0.000238	0.000416	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000238	0.000416	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000237	0.000415	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000237	0.000415	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—SLC26A1—nephrolithiasis	0.000235	0.00041	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—APRT—nephrolithiasis	0.000235	0.00041	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—SLC26A1—nephrolithiasis	0.000228	0.000398	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—APRT—nephrolithiasis	0.000228	0.000398	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CHRM3—nephrolithiasis	0.000223	0.00039	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000211	0.00037	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000211	0.00037	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PTH—nephrolithiasis	0.000204	0.000357	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—AQP1—nephrolithiasis	0.000182	0.000318	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000172	0.000301	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000169	0.000295	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—AQP1—nephrolithiasis	0.000167	0.000292	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CHRM3—nephrolithiasis	0.000164	0.000288	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—AQP1—nephrolithiasis	0.000162	0.000284	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PTH—nephrolithiasis	0.000157	0.000275	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CHRM3—nephrolithiasis	0.000151	0.000264	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CHRM3—nephrolithiasis	0.000147	0.000257	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000147	0.000256	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000138	0.000241	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000131	0.000228	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000123	0.000215	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000111	0.000194	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—APRT—nephrolithiasis	0.000111	0.000194	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000105	0.000183	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000105	0.000183	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SPP1—nephrolithiasis	0.000102	0.000179	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GRHPR—nephrolithiasis	9.03e-05	0.000158	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—AGXT—nephrolithiasis	8.05e-05	0.000141	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—AQP1—nephrolithiasis	7.92e-05	0.000138	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SPP1—nephrolithiasis	7.91e-05	0.000138	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—AQP1—nephrolithiasis	7.46e-05	0.00013	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CHRM3—nephrolithiasis	7.16e-05	0.000125	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APRT—nephrolithiasis	6.84e-05	0.00012	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	6.84e-05	0.00012	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CHRM3—nephrolithiasis	6.75e-05	0.000118	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—AQP1—nephrolithiasis	4.88e-05	8.53e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CHRM3—nephrolithiasis	4.41e-05	7.71e-05	CbGpPWpGaD
